Pharming (NASDAQ:PHAR) reported quarterly earnings of $0.07 per share which beat the analyst consensus estimate of $0.01 by 775 percent. This is a 40 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $106.500 million which beat the analyst consensus estimate of $105.190 million by 1.25 percent. This is a 14.89 percent increase over sales of $92.700 million the same period last year.